Evidence map›Paper›PMID 35843113›Full record

ArticleDiagnostic microbiology and infectious disease2022

Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department.

Aurore Bousquet, Sébastien Larréché, Christine Bigaillon, Alexandre Woloch, Léa Thomas, Pierre Louis Conan, Audrey Mérens

Abstract read
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aurore BousquetMicrobiology unit, Begin teaching military hospital, Saint-Mandé, France. Electronic address: aurorebousquet@yahoo.fr.
Sébastien LarréchéMicrobiology unit, Begin teaching military hospital, Saint-Mandé, France.
Christine BigaillonMicrobiology unit, Begin teaching military hospital, Saint-Mandé, France.
Alexandre WolochEmergency unit, Begin teaching military hospital, Saint-Mandé, France.
Léa ThomasEmergency unit, Begin teaching military hospital, Saint-Mandé, France.
Pierre Louis ConanDepartment of Infectious Diseases and Tropical Medicine, Begin teaching military hospital, Saint-Mandé, France.
Audrey MérensMicrobiology unit, Begin teaching military hospital, Saint-Mandé, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We compared ID Now™ and Hologic® Panther Aptima™ for the detection of SARS-COV-2. ID Now™ showed a positive and negative percent agreement of 86.9% and 99.7% respectively. This facilitates faster clinical decision-making, along with the rapid implementation of infection control measures, and improvement of patient flow in the emergency department toward inpatient wards.

Indexed as

COVID-19SARS-CoV-2Clinical Laboratory TechniquesCOVID-19 TestingEmergency Service, HospitalHumansMolecular Diagnostic TechniquesRetrospective StudiesSensitivity and SpecificityCOVID-19Hologic Panther Point of care deviceID NOWSARS-CoV-2

Identifiers

PMID35843113
PMCPMC9188679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.